PCRX
Pacira BioSciences, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +30.0% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +2 | 30.85M | $781.81M | +7 | −4 |
| Q1 2026 | 89 | -5 | 30.76M | $694.94M | +2 | −7 |
| Q4 2025 | 94 | -1 | 36.25M | $938.05M | — | −1 |
| Q3 2025 | 19 | +1 | 24.74M | $637.46M | +2 | −1 |
| Q2 2025 | 15 | 0 | 22.66M | $541.65M | +1 | −1 |
| Q1 2025 | 12 | -3 | 10.29M | $255.59M | — | −3 |
| Q4 2024 | 15 | +1 | 11.71M | $220.69M | +1 | — |
| Q3 2024 | 13 | 0 | 9.23M | $138.98M | +1 | −1 |
| Q2 2024 | 13 | — | 6.89M | $197.00M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 1.98M | -4.2% | $29.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 1.96M | +307.3% | $29.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 1.96M | +307.3% | $29.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.96M | +307.3% | $29.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 1.15M | +2058.1% | $17.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 1.09M | -0.2% | $16.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 1.09M | -0.2% | $16.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 606.04K | Nuevo | $9.12M | 0.0% | New | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 546.21K | +707.8% | $8.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 546.21K | +707.8% | $8.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 546.21K | +707.8% | $8.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 524.95K | -46.0% | $7.90M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 524.95K | -46.0% | $7.90M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 454.65K | -6.7% | $6.84M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 454.65K | -6.7% | $6.84M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 454.65K | -6.7% | $6.84M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Wellington Management ✦ | 454.65K | -6.7% | $6.84M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 446.53K | +48.8% | $6.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 446.53K | +48.8% | $6.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Norges Bank ✦ (pasivo) | 269.30K | +28.2% | $4.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 90.91K | +214.3% | $1.37M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Two Sigma Investments ✦ | 69.46K | -8.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 50.72K | -79.6% | $764,000 | 0.0% | ▼ Trim | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Millennium Management | $9.12M | 0.0% |
Posición cerrada
| Baillie Gifford | $23.06M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 3 tenedores, 13.02M acciones, $12.57M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.